Literature DB >> 12848470

Microbial virulence determinants and the pathogenesis of urinary tract infection.

James R Johnson1.   

Abstract

The most frequent and best-studied agent of urinary tract infection (UTI) is Escherichia coli, which serves as a useful model pathogen for understanding microbial virulence in relation to UTI pathogenesis. The E. coli strains that cause most UTIs and other extraintestinal E. coli infections represent a highly specialized subset of the total E. coli population. The enhanced virulence potential of such strains, which collectively are known as uropathogenic E. coli or extraintestinal pathogenic E. coli (ExPEC), is thought to be caused mainly by their multiple virulence factors. These virulence factors include diverse adhesins, siderophores, toxins, polysaccharide coatings, and other properties that assist the bacteria in avoiding or subverting host defenses, injuring or invading host cells and tissues, and stimulating a noxious inflammatory response. Although the true evolutionary basis for ExPEC is unknown, the virulence factors of ExPEC serve as useful epidemiologic markers and in the future may provide effective targets for anti-UTI interventions.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12848470     DOI: 10.1016/s0891-5520(03)00027-8

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN: 0891-5520            Impact factor:   5.982


  36 in total

Review 1.  Next-generation and whole-genome sequencing in the diagnostic clinical microbiology laboratory.

Authors:  W M Dunne; L F Westblade; B Ford
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-06-08       Impact factor: 3.267

2.  Uropathogenic Escherichia coli induces chronic pelvic pain.

Authors:  Charles N Rudick; Ruth E Berry; James R Johnson; Brian Johnston; David J Klumpp; Anthony J Schaeffer; Praveen Thumbikat
Journal:  Infect Immun       Date:  2010-11-15       Impact factor: 3.441

3.  Escherichia coli CFT073 Fitness Factors during Urinary Tract Infection: Identification Using an Ordered Transposon Library.

Authors:  Allyson E Shea; Juan Marzoa; Stephanie D Himpsl; Sara N Smith; Lili Zhao; Lisa Tran; Harry L T Mobley
Journal:  Appl Environ Microbiol       Date:  2020-06-17       Impact factor: 4.792

Review 4.  [Treatment and prophylaxis of recurrent urinary tract infections].

Authors:  B Banas; B K Krämer
Journal:  Internist (Berl)       Date:  2005-12       Impact factor: 0.743

5.  Relationship between Escherichia coli strains causing urinary tract infection in women and the dominant faecal flora of the same hosts.

Authors:  E Moreno; A Andreu; T Pérez; M Sabaté; J R Johnson; G Prats
Journal:  Epidemiol Infect       Date:  2006-01-26       Impact factor: 2.451

6.  A new O-antigen gene cluster has a key role in the virulence of the Escherichia coli meningitis clone O45:K1:H7.

Authors:  Céline Plainvert; Philippe Bidet; Chantal Peigne; Valérie Barbe; Claudine Médigue; Erick Denamur; Edouard Bingen; Stéphane Bonacorsi
Journal:  J Bacteriol       Date:  2007-09-28       Impact factor: 3.490

7.  Recurrent urinary tract infections in healthy and nonpregnant women.

Authors:  Matthew Glover; Cristiano G Moreira; Vanessa Sperandio; Philippe Zimmern
Journal:  Urol Sci       Date:  2014-03

8.  Transcriptional responses of uropathogenic Escherichia coli to increased environmental osmolality caused by salt or urea.

Authors:  Benjamin Withman; Thusitha S Gunasekera; Pavani Beesetty; Richard Agans; Oleg Paliy
Journal:  Infect Immun       Date:  2012-10-22       Impact factor: 3.441

Review 9.  Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis.

Authors:  S M Jacobsen; D J Stickler; H L T Mobley; M E Shirtliff
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

10.  A phylogenetic group of Escherichia coli associated with active left-sided inflammatory bowel disease.

Authors:  Andreas M Petersen; Eva M Nielsen; Eva Litrup; Jørn Brynskov; Hengameh Mirsepasi; Karen A Krogfelt
Journal:  BMC Microbiol       Date:  2009-08-20       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.